Insecticides India LtdQ1 FY23
Insecticides India Ltd
Q1 FY23 Earnings Call Analysis
Management growth scorecard
Revenue
Category 3
Margin
Category 2
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- →Targeting double-digit revenue growth of 10% to 12% in fiscal year 2024.
- →Expecting significant growth in exports, aiming to double export sales compared to the previous year.
- →Planning gross sales of over INR 800 crores in Q1, supported by new product launches and higher sales targets.
- →New patented and branded products (e.g., Shinwa, Hachiman, Torry, Mission) expected to contribute substantially, with Focused Maharatna and Maharatna segments projected to account for at least 60% of sales in FY '24.
- →Inventory liquidation and market normalization anticipated to improve margins and profitability.
- →Anticipate recovery and growth as agricultural season picks up, with positive impact expected from monsoon timing and market conditions.
- →Expansion of product portfolio and R&D initiatives aimed at sustaining growth and entering new markets continuously.
Margin guidance
Category 2- →FY '24 expected to be challenging due to inventory liquidation and market pressures, but growth is anticipated.
- →Revenue growth target for FY '24 is double-digit, around 10%-12%.
- →EBITDA margin guidance for FY '24 is subdued at 9%-10%, with improvement expected post Q1 as lower cost inventories come into effect.
- →The company aims to increase profitability beyond current 10% EBITDA margin to 12%+ in FY '25 when market normalizes and new, higher-margin patented products gain traction.
- →New product launches, including patented products, expected to drive better margins and growth over the next few years.
- →Export growth projected to double in FY '24, potentially boosting earnings.
- →Performance is expected to improve from Q2 FY '24 onwards, assuming favorable monsoon and easing of Chinese pricing pressures.
- →Long-term growth supported by R&D, backward integration, introduction of mega brands, and new markets expansion.
Sign up free to read the full earnings analysis
Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Insecticides India Ltd and 1,400+ other companies.
Fundraise plans
- →There is no mention of any current or future fundraising plans through debt or equity in the provided transcript.
- →The management did not discuss raising capital or issuing shares during the call.
- →Rajesh Aggarwal confirmed no promoter share offloading or reduction has occurred; in fact, promoter holding increased due to past buyback.
- →The focus is on internal growth through new product launches, R&D, backward integration, and improving profitability rather than external fundraising.
- →No specific financial plans involving raising capital were shared for the near future.
Order book
- →The transcript does not explicitly mention a specific current or expected order book or pending orders value.
- →Rajesh Aggarwal mentions strong sales targets, notably planning gross sales of INR 800 crores-plus in the first quarter, indicating a strong order pipeline.
- →Demand for products remains good domestically, with no significant stocks in the market, suggesting steady off-take.
- →Chinese inventory is still flowing into the market, which affects pricing but also indicates ongoing procurement and orders.
- →The company is optimistic about growth from Q2 onwards, assuming normalization post monsoon.
- →While exact order book figures aren’t disclosed, the focus on inventory liquidation and ambitious Q1 sales targets implies a healthy pending order scenario.
Capex plans
Yes- →Completed project at Chopanki; plant is up and functioning with full-fledged technical production.
- →New molecules from Chopanki unit have already been launched in the market.
- →Announced a new plant at Sotanala (Behror); company in final stages of acquisition with registry expected in early June.
- →Plans to start production of formulations and biologicals from the new site, with technicals production as Phase 2 in a phased approach.
- →Focus on backward integration initiatives supporting business momentum and growth.
How does Insecticides India Ltd rank vs peers in Fertilizers & Agrochemicals?
Pro feature1Insecticides India Ltd
Rev 3Mar 2
See full Fertilizers & Agrochemicals sector rankings
Unlock with ProWant more stocks like Insecticides India Ltd?
Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.
Build my portfolio